Pet Herbal Supplements Market (By Product Type: Omega 3 fatty acids, Probiotics & prebiotics; By Application; By Animal Type; By Dosage Form; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global pet herbal supplements market was estimated at USD 883.82 million in 2023 and it is expected to surpass around USD 2,385.77 million by 2033, poised to grow at a CAGR of 10.44% from 2024 to 2033.

Pet Herbal Supplements Market Size 2024 to 2033

Key Pointers

  • North America region dominated the largest revenue share of 34% in 2023.
  • Asia Pacific region is expected to expand at the noteworthy CAGR of 11.05% over the forecast period.
  • By Product Type, the multivitamins & minerals segment held the largest revenue share of 31% in 2023.
  • By Product Type, the CBD segment is predicted to grow at the notable CAGR of 11.05% between 2024 to 2033.
  • By Application, the digestive support segment registered the maximum market share of 25% in 2023.
  • By Application, the others segment is predicted to grow the noteworthy CAGR of 15.35% during the forecast period.
  • By Animal Type, the cats segment is anticipated to grow at the fastest CAGR of 10.08% between 2024 to 2033.
  • By Dosage Form, the gummies & chewable segment led the market with a revenue share of over 34% in 2023.
  • By Distribution Channel, the offline contributed the largest market share of 62% in 2023.

Pet Herbal Supplements Market Overview

The market is primarily driven by a growing awareness among pet owners about the potential benefits of herbal supplements. Pet owners are increasingly seeking alternatives to conventional medications, drawn by the perception that herbal supplements offer gentler and safer options for supporting their pets' health. This shift is underscored by a broader societal trend towards health and wellness, extending to the care of companion animals.

Pet Herbal Supplements Market Growth Factors

The robust growth observed in the pet herbal supplements market can be attributed to several key factors. Primarily, an increasing awareness among pet owners regarding the potential advantages of herbal supplements has fueled market expansion. Pet owners are actively seeking alternatives to traditional medications, drawn by the perceived safety and gentleness of herbal options. This shift is part of a broader societal trend emphasizing natural and holistic approaches to health, extending to the care of companion animals.

Report Scope of the Pet Herbal Supplements Market

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 10.44%
Market Revenue by 2033 USD 2,385.77 million
Revenue Share of North America in 2023 34%
CAGR of Asia Pacific from 2024 to 2033 11.05%
Base Year 2023
Forecast Period 2024 to 2033
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)Companies Covered

 

Pet Herbal Supplements Market Dynamics

Drivers

  • Increasing Consumer Awareness: The pet herbal supplements market is being driven by a rising awareness among pet owners about the potential benefits of herbal supplements. This heightened awareness is a result of increased access to information through various channels, including online resources, pet care forums, and educational initiatives by industry players.
  • Humanization of Pets: The evolving status of pets as integral family members has led to a shift in consumer behavior. Pet owners are more willing to invest in premium products, including herbal supplements, to enhance the overall well-being of their furry companions. This cultural shift contributes significantly to the market's growth.

Restraints

  • Limited Scientific Validation: A key restraint is the limited scientific validation of the efficacy and safety of certain herbal supplements for pets. The absence of comprehensive research on the long-term effects and interactions of these supplements may contribute to skepticism among pet owners and hinder widespread acceptance.
  • Skepticism and Traditional Mindsets: Some pet owners remain skeptical about the efficacy of herbal supplements, clinging to traditional veterinary treatments. Overcoming ingrained mindsets and fostering trust in the efficacy of herbal alternatives may take time and concerted efforts in education and awareness campaigns.

Opportunities

  • Transparency and Quality Assurance: Emphasizing transparency in product labeling and ensuring quality assurance can be a competitive advantage. Companies that invest in quality control measures, including standardized manufacturing processes and ingredient sourcing, are likely to gain consumer trust and loyalty.
  • Expanding Product Innovation: The pet herbal supplements market presents significant opportunities for product innovation. Companies can capitalize on the growing demand by developing new and specialized herbal formulations to address specific pet health needs, fostering diversity and catering to a broader consumer base.

Product Insights

The multivitamins & minerals segment dominated the market with revenue share of 31% in 2023. Pet owners are using multivitamins and mineral supplements as a proactive measure to enhance their pets' overall well-being. These supplements can help maintain optimal health, support immune function, promote healthy skin and coat, and more.

The CBD segment is anticipated to grow at the fastest CAGR of 11.05% over the forecast period. The rising demand for herbal CBD supplements is anticipated to boost market growth throughout the forecast period. The usage of CBD-based pet products to reduce pet anxiety and increase all-around pet wellness worldwide has increased, according to statistics from the American Pet Products Association released in September 2023. CBD supplements support cerebral stimulation, reduce boredom, and ease anxiety in pet owners through CBD-based herbal pet supplement products.

Application Insights

The digestive support segment held the largest revenue share of 25% in 2023. Growing awareness about the benefits of herbal supplements for several pet digestive issues drives the segment's growth. Furthermore, the growing use of herbal digestive supplements as a preventive measure to maintain their pet's digestive health is expected to supplement segment growth. Regular use of these supplements may aid in maintaining a healthy digestive tract and prevent problems in the future. 

The others (energy and electrolytes, growth promoters, etc.) segment is anticipated to grow the fastest CAGR of 15.35% during the forecast period. Synthetic medications or stimulants that boost energy in pets may have potential side effects or risks. Thus, herbal supplements are often considered safer and gentler, with fewer adverse effects for boosting pet energy levels. Furthermore, owners of working dogs, such as police dogs, search and rescue dogs, and sporting dogs, are using energy-promoting herbal supplements to help their animals perform at their best during physically demanding activities.

Animal Insights

The dogs segment held the highest share of the market in 2023. Dogs are the most widely adopted pets in the world and have a very high adoption rate. The American Pet Products Association's National Pet Owners Survey indicates that 69.0 million American households have dogs. Companies are offering new dog supplements, fueling the market's growth over the forecast period. For instance, in October 2021, the Mars and Affiliates brand Greenies launched a line of canine vitamins with an emphasis on mobility, immune system support, and skin and coat health.

The cats segment is expected to grow at the notable CAGR of 10.08% over the forecast period. Cats have been shown to offer their owners more comfort and companionship, which has led to a rise in the demand for cat food and supplement products

Dosage Form Insights

The gummies & chewable segment dominated the market with a revenue share of over 34% in 2023. Many companion animals, including cats and dogs, have difficulty swallowing tablets or capsules or simply do not enjoy the sensation. Chewable supplements are the best option in these circumstances since pets instinctively chew all food, which drives this segment's growth.

The other segment is projected to grow at the fastest CAGR of around 12.05% during the forecast period. Other segment includes gels, jelly, and sprinkle formulations. This supplement is more readily absorbed than tablets or pills. It is simple to administer and incorporate into foods and beverages, which will increase the product's popularity throughout the forecast period.

Distribution Channel Insights

The offline segment led the market with a revenue share of 62% in 2023. On the other hand, the online segment is anticipated to register the fastest CAGR of around 12.06% during the forecast period. This is because a significant number of pet owners choose brick-and-mortar stores as their preferred channel of distribution. However, e-commerce and other internet outlets have become more popular recently. To boost sales, several offline retailers started letting customers choose between ordering online and making a purchase in person.

The growing demand for e-commerce has created lucrative growth in the online segment over the forecast period. Still, a substantial shift towards online pet supplement shopping has occurred since 2020. In North America, store-based retailing accounted for 66% of all pet supplement sales in 2019, falling to 53% in 2020. For instance, according to the data published by Kerry Group plc. in March 2021, for supplements, pet owners have been gradually moving away from brick-and-mortar stores and towards online retailers.

Regional Insights

North America held the largest revenue share of 34% in 2023. The presence of key players, the growing trend of pet humanization, and the enhanced quality of pet products are the main drivers of the region's large market share. The leading companies are increasing their market presence by establishing subsidiaries, which are expected to propel the regional market. For instance, Pet Honesty introduced its pet health supplements in August 2023 at PetSmart, the country's top pet retailer

The Asia Pacific region is expected to expand at the highest CAGR of 11.05% from 2024 to 2033. The growing pet population and concern about the well-being of pets are the factors that are anticipated to propel the market growth in the region. For instance, Wai Yuen Tong Medicine Co., Ltd. diversified into the pet supplement market in August 2020 by releasing a line of labeled herbal supplements for pets.

Pet Herbal Supplements Market Key Companies

  • Blackmores
  • NaturVet (The Garmon Corp.)
  • Natural Dog Company Inc.
  • AdvaCare Pharma
  • Pet Natural Remedies
  • Dorwest Herbs Ltd.
  • Only Natural Pet LLC
  • AMORVET
  • Rockwell Pets Pro
  • Nutri-Pet Research, Inc.
  • Health Extension

Pet Herbal Supplements Market Report Segmentations:

By Product Type

  • Omega 3 Fatty Acids
  • Probiotics & Prebiotics
  • Multivitamins & Minerals
  • CBD
  • Proteins & Peptides
  • Others

By Application

  • Digestive Support
  • Immunity Support
  • Skin & Coat
  • Calming/Stress/Anxiety
  • Joint Health Support
  • Kidney Health
  • Liver Health
  • Respiratory Health
  • Others (energy and electrolytes, growth promoters, etc.)

By Animal Type

  • Dogs
  • Cats
  • Horses
  • Others

By Dosage Form

  • Tablets & Capsules
  • Gummies & Chewable
  • Powders
  • Liquids
  • Other

By Distribution Channel

  • Online
  • Offline
    • Pet Specialty stores                      
    • Retail
    • Others

By Regional

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

The global pet herbal supplements market size was reached at USD 883.82 million in 2023 and it is projected to hit around USD 2,385.77 million by 2033.

The global pet herbal supplements market is growing at a compound annual growth rate (CAGR) of 10.44% from 2024 to 2033.

The North America region has accounted for the largest pet herbal supplements market share in 2023.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pet Herbal Supplements Market 

5.1. COVID-19 Landscape: Pet Herbal Supplements Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pet Herbal Supplements Market, By Product Type

8.1. Pet Herbal Supplements Market, by Product Type, 2024-2033

8.1.1. Omega 3 Fatty Acids

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Probiotics & Prebiotics

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Multivitamins & Minerals

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. CBD

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Proteins & Peptides

8.1.5.1. Market Revenue and Forecast (2021-2033)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Pet Herbal Supplements Market, By Application

9.1. Pet Herbal Supplements Market, by Application, 2024-2033

9.1.1. Digestive Support

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Immunity Support

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Skin & Coat

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Calming/Stress/Anxiety

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Joint Health Support

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.6. Kidney Health

9.1.6.1. Market Revenue and Forecast (2021-2033)

9.1.7. Liver Health

9.1.7.1. Market Revenue and Forecast (2021-2033)

9.1.8. Respiratory Health

9.1.8.1. Market Revenue and Forecast (2021-2033)

9.1.9. Others (energy and electrolytes, growth promoters, etc.)

9.1.9.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Pet Herbal Supplements Market, By Animal Type 

10.1. Pet Herbal Supplements Market, by Animal Type, 2024-2033

10.1.1. Dogs

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Cats

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Horses

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Pet Herbal Supplements Market, By Dosage Form

11.1. Pet Herbal Supplements Market, by Dosage Form, 2024-2033

11.1.1. Tablets & Capsules

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Gummies & Chewable

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Powders

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Liquids

11.1.4.1. Market Revenue and Forecast (2021-2033)

11.1.5. Other

11.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Pet Herbal Supplements Market, By Distribution Channel

12.1. Pet Herbal Supplements Market, by Distribution Channel, 2024-2033

12.1.1. Online

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. Offline

12.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 13. Global Pet Herbal Supplements Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.1.2. Market Revenue and Forecast, by Application (2021-2033)

13.1.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.1.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.1.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.1.6.2. Market Revenue and Forecast, by Application (2021-2033)

13.1.6.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.1.6.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.1.7. Market Revenue and Forecast, by Distribution Channel (2021-2033) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.1.8.2. Market Revenue and Forecast, by Application (2021-2033)

13.1.8.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.1.8.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.1.8.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.2.2. Market Revenue and Forecast, by Application (2021-2033)

13.2.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.2.4. Market Revenue and Forecast, by Dosage Form (2021-2033) 

13.2.5. Market Revenue and Forecast, by Distribution Channel (2021-2033) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.2.6.2. Market Revenue and Forecast, by Application (2021-2033)

13.2.6.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.2.7. Market Revenue and Forecast, by Dosage Form (2021-2033) 

13.2.8. Market Revenue and Forecast, by Distribution Channel (2021-2033) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.2.9.2. Market Revenue and Forecast, by Application (2021-2033)

13.2.9.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.2.10. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.2.11. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.2.12.2. Market Revenue and Forecast, by Application (2021-2033)

13.2.12.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.2.12.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.2.13. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.2.14.2. Market Revenue and Forecast, by Application (2021-2033)

13.2.14.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.2.14.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.2.15. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.3.2. Market Revenue and Forecast, by Application (2021-2033)

13.3.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.3.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.3.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.3.6.2. Market Revenue and Forecast, by Application (2021-2033)

13.3.6.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.3.6.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.3.7. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.3.8.2. Market Revenue and Forecast, by Application (2021-2033)

13.3.8.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.3.8.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.3.9. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.3.10.2. Market Revenue and Forecast, by Application (2021-2033)

13.3.10.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.3.10.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.3.10.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.3.11.2. Market Revenue and Forecast, by Application (2021-2033)

13.3.11.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.3.11.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.3.11.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.4.2. Market Revenue and Forecast, by Application (2021-2033)

13.4.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.4.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.4.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.4.6.2. Market Revenue and Forecast, by Application (2021-2033)

13.4.6.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.4.6.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.4.7. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.4.8.2. Market Revenue and Forecast, by Application (2021-2033)

13.4.8.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.4.8.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.4.9. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.4.10.2. Market Revenue and Forecast, by Application (2021-2033)

13.4.10.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.4.10.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.4.10.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.4.11.2. Market Revenue and Forecast, by Application (2021-2033)

13.4.11.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.4.11.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.4.11.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.5.2. Market Revenue and Forecast, by Application (2021-2033)

13.5.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.5.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.5.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.5.6.2. Market Revenue and Forecast, by Application (2021-2033)

13.5.6.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.5.6.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.5.7. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product Type (2021-2033)

13.5.8.2. Market Revenue and Forecast, by Application (2021-2033)

13.5.8.3. Market Revenue and Forecast, by Animal Type (2021-2033)

13.5.8.4. Market Revenue and Forecast, by Dosage Form (2021-2033)

13.5.8.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

Chapter 14. Company Profiles

14.1. Blackmores

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. NaturVet (The Garmon Corp.)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Natural Dog Company Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. AdvaCare Pharma

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Pet Natural Remedies

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Dorwest Herbs Ltd.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Only Natural Pet LLC

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. AMORVET

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Rockwell Pets Pro

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Nutri-Pet Research, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert